Venus Concept Inc. (OTC: VERO)

Venus Concept Inc., a globally recognized medical technology company, is renowned for its development, commercialization, and delivery of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. Utilizing proprietary multipolar pulsed technology (MP)2, the company's systems empower medical professionals to offer an array of aesthetic procedures with minimal downtime and discomfort. The company directly operates in 14 international markets with 11 direct offices located in the United States, Canada, United Kingdom, Japan, Mexico, Spain, Germany, Australia, China, Hong Kong, and Israel.

Venus Concept's business activities encompass the creation of innovative aesthetic and hair restoration solutions designed to tackle the constraints of conventional procedures and technologies. The company's offerings include the ARTAS system, a robotically assisted minimally invasive solution for hair restoration; the NeoGraft system, a minimally invasive solution for hair restoration; and a series of aesthetic solutions harnessing the proprietary MP2 technology for multipolar radiofrequency (RF) and magnetic pulse synthesis. Additionally, Venus Concept has established a strong presence in non-traditional markets, extending beyond dermatology and plastic surgery into family medicine, general practitioners, and aesthetic medical spas.

The company's revenue is generated from a variety of sources, including the sale of products and services such as system revenue, marketing supplies and kits, consumables and disposables, service revenue, and replacement applicators/handpieces. Venus Concept's primary products, including Venus Viva, Venus Viva MD, Venus Legacy, Venus Versa, Venus Versa Pro, Venus Velocity, Venus Bliss, Venus Bliss Max, Venus Epileve, Venus Fiore, ARTAS, ARTAS iX, and AI.ME, cater to various aesthetic procedures such as skin tightening, cellulite reduction, and body contouring.

As a leader in the medical aesthetic and hair restoration industry, Venus Concept maintains a competitive edge through its innovative proprietary MP2 technology and the ARTAS system. These solutions enable more natural, aesthetically pleasing outcomes for hair restoration procedures, while also offering minimally invasive and non-invasive aesthetic procedures with reduced downtime and discomfort. The company's robust portfolio of products appeals to a diverse range of medical professionals, including plastic surgeons, dermatologists, and aesthetic medical spas, as well as general and family practitioners.

In terms of marketing and sales, Venus Concept employs a blend of direct sales and distribution agreements to reach its customers. The company has a direct sales force in the United States and select international markets, complemented by distributors in countries where it does not operate directly. Venus Concept's intellectual property portfolio consists of 16 issued U.S. patents, 4 pending U.S. patent applications, 27 issued foreign counterpart patents, and 15 pending foreign counterpart patent applications. The company also boasts trademark registrations, pending trademark applications, and common law trademark rights.